Assistant ProfessorDepartment of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA, United States
49: A Prospective Evaluation of a Modified Hepatic Arterial Infusion Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases
Thursday, March 21, 20243:12pm – 3:22pm ET